China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Research Report Forecast 2017-2021

March 2017 | 116 pages | ID: C07A1033465EN
S&P Consulting

Abstracts

The China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Non-alcoholic Fatty Liver Disease (NAFLD) Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Non-alcoholic Fatty Liver Disease (NAFLD) Drug market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:

Conatus Pharmaceuticals
Daewoong Pharmaceutical
Galmed International
Kyorin Pharmaceutical
Metabolic Solutions Development
Novartis AG
Phenex Pharmaceuticals
Raptor Pharmaceuticals
TCM Biotech International

China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market: Product Segment Analysis

Type 1
Type 2
Type 3

China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market: Application Segment Analysis

Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Research Report Forecast 2017-2021

CHAPTER 1 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Segmentation by Type
  1.2.1 China Production Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type 1n 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Segmentation by Application
  1.3.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 China Market Size Sales (Value) and Revenue (Volume) of Non-alcoholic Fatty Liver Disease (NAFLD) Drug (2012-2021)

CHAPTER 2 CHINA ECONOMIC IMPACT ON NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG INDUSTRY

2.1 China Macroeconomic Environment Analysis
  2.1.1 China Macroeconomic Analysis
  2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry

CHAPTER 3 CHINA NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MARKET COMPETITION BY MANUFACTURERS

3.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production and Share by Manufacturers (2015 and 2016)
3.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Share by Manufacturers (2015 and 2016)
3.3 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturing Base Distribution, Production Area and Product Type
3.5 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Competitive Situation and Trends
  3.5.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Concentration Rate
  3.5.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 CHINA NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2012-2017)

4.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity, Production and Growth (2012-2017)
4.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth (2012-2017)
4.3 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption, Export and Import (2012-2017)

CHAPTER 5 CHINA NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production and Market Share by Type (2012-2017)
5.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Type (2012-2017)
5.3 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Price by Type (2012-2017)
5.4 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Growth by Type (2012-2017)

CHAPTER 6 CHINA NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MARKET ANALYSIS BY APPLICATION

6.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption and Market Share by Application (2012-2017)
6.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

CHAPTER 7 CHINA NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MANUFACTURERS ANALYSIS

7.1 Conatus Pharmaceuticals
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Product Type, Application and Specification
  7.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Business Overview
7.2 Daewoong Pharmaceutical
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Product Type, Application and Specification
  7.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Business Overview
7.3 Galmed International
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Product Type, Application and Specification
  7.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Business Overview
7.4 Kyorin Pharmaceutical
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Product Type, Application and Specification
  7.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Business Overview
7.5 Metabolic Solutions Development
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
  7.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Business Overview
7.6 Novartis AG
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Product Type, Application and Specification
  7.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Business Overview
7.7 Phenex Pharmaceuticals
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Product Type, Application and Specification
  7.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Business Overview
7.8 Raptor Pharmaceuticals
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
  7.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Business Overview
7.9 TCM Biotech International
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
  7.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Business Overview

CHAPTER 8 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MANUFACTURING COST ANALYSIS

8.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
9.4 Downstream Buyers

CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

CHAPTER 12 CHINA NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MARKET FORECAST (2017-2021)

12.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue Forecast (2017-2021)
12.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Consumption Forecast by Regions (2017-2021)
12.3 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Forecast by Type (2017-2021)
12.4 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast by Application (2017-2021)
12.5 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Price Forecast (2017-2021)

CHAPTER 13 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure China Production Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type 1n 2016
Table Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Share by Application in 2016
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue (Million USD) and Growth Rate (2012-2021)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity of Key Manufacturers (2015 and 2016)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity of Key Manufacturers in 2015
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity of Key Manufacturers in 2016
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production of Key Manufacturers (2015 and 2016)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Share by Manufacturers
Figure 2016 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Share by Manufacturers
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers
Table 2016 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue Share by Manufacturers
Table China Market Non-alcoholic Fatty Liver Disease (NAFLD) Drug Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Non-alcoholic Fatty Liver Disease (NAFLD) Drug Average Price of Key Manufacturers in 2015
Table Manufacturers Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Type
Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share of Top 3 Manufacturers
Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Church & Dwight Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table Conatus Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table Daewoong Pharmaceutical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table Galmed International Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table Kyorin Pharmaceutical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table Metabolic Solutions Development Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table Novartis AG Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table Phenex Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table Raptor Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Table TCM Biotech International Basic Information, Manufacturing Base, Production Area and Its Competitors
Table TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share (2012-2017)
Figure Production Revenue Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type (2012-2017)
Figure 2015 Revenue Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Price by Type (2012-2017)
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Growth by Type (2012-2017)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption by Application (2012-2017)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Share by Application (2012-2017)
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Market Share by Application in 2015
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Growth Rate by Application (2012-2017)
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Growth Rate by Application (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industrial Chain Analysis
Table Raw Materials Sources of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
Table Major Buyers of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table Distributors/Traders List
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity, Production and Growth Rate Forecast (2017-2021)
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate Forecast (2017-2021)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production, Import, Export and Consumption Forecast (2017-2021)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Forecast by Type (2017-2021)
Table China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast by Application (2017-2021)

COMPANIES MENTIONED

Conatus Pharmaceuticals, Daewoong Pharmaceutical, Galmed International, Kyorin Pharmaceutical, Metabolic Solutions Development, Novartis AG, Phenex Pharmaceuticals, Raptor Pharmaceuticals, TCM Biotech International, Tobira Therapeutics, Verva Pharmaceuticals, Zafgen